Catalyst Wire Dossier Catalyst Wire Dossier

SABER®-Bupivacaine

bupivacaine · Durect
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for SABER®-Bupivacaine, covering 2021-05-05 to 2021-06-09. Get the full timeline:

Most recent: Clinical Trial Update: An International Trial to Evaluate the Efficacy and Safety of SABER®-Bupivacaine for Postoperative Pain Control in Patients Following Arthroscopic Shoulder Surgery [Phase 2]

See pricing